Informationes plurimae ― Latine

Scleroderma Morbus rarus est circa telas nota afficiens, ostendens cutem induratam et alias partes corporis interdum impacto. Duo genera principalia sunt: ​​ systemic sclerosis , quae cutem involvit duritiam et viscera interiora, ac localized scleroderma , quae etiam morphea nota est, quae proprie cuti et fibras subest circumscripta, benigno et se continenti cursu. Etsi scleroderma localatum raro est eiusque causa obscura est, recens investigatio suadet potest etiam organa interna afficere ac varias quaestiones sanitatis ducere. Praematuro curatio pendet ne inpedimenta, gravitati potentiae localized scleroderma posita.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.

Morphea , etiam scleroderma locale notum, rara autoimmune morbus est textus connectens afficiens. Variis modis ostendere potest, et non admodum commune, cum de causis 0. 4 - 2. 7 per 100,000 hominum quolibet anno. Morphea saepe in haedis inter 2 et 14 annos cernitur, et puellas saepius quam pueros afficere tendit.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.